It is shown that introducing a pH-sensitive linker in C16 lipid- and C22 lipid-conjugated ASOs increases endosomal remodeling events detected via a Galectin 9 reporter imaging assay, despite similar levels of ASO cellular uptake, and incorporation of a pH-sensitive linker can lead to improved gene silencing in vitro.
Abstract
Oligonucleotide therapeutics have great potential for the treatment of previously “undruggable” human diseases; however, their broad utility is limited by challenges in delivery and achieving sufficient endosomal escape. Systemic delivery of antisense oligonucleotides (ASOs) results in their primary accumulation in the liver and kidneys, limiting their effectiveness in targeting RNAs in other tissues. Conjugation to specific lipids has been employed to boost productive delivery of oligonucleotides to nonhepatic tissues such as heart and skeletal muscle. Once oligonucleotides have entered the right cell type, they then need to escape the endosomal lipid bilayer to reach their RNA targets in the nucleus and cytoplasm. In this article, we show that introducing a pH-sensitive linker in C16 lipid- and C22 lipid-conjugated ASOs increases endosomal remodeling events detected via a Galectin 9 reporter imaging assay, despite similar levels of ASO cellular uptake. Furthermore, incorporation of a pH-sensitive linker can lead to improved gene silencing in vitro. These data suggest that decoupling the lipid from the ASO is a promising approach to improve ASO endosomal escape and activity. Therefore, pH-sensitive linkers offer a novel strategy to expand the potential use of oligonucleotide therapeutics.
Novel pH-triggered RNA-LNPs (ZK2 LNPs) that comprise PEG-lipid oxime conjugates (5 mol%), prepared in situ using pH-reversible aminoxy-aldehyde click chemistry represent a powerful next generation LNP technology and demonstrate excellent LNP tolerability in vivo.
Zdeněk Kratochvíl, Dattary Shivajirao Bhosale, Melanie Schürz et al.· International journal of pha...· 0 citations
The importance of formulation optimization in improving nucleic acid delivery is highlighted and practical insights for enhancing peptide- and lipid-based therapeutic platforms are provided.
D. Daniele, Z. Hein, O. Saher et al.· International Journal of Pha...· 0 citations
It is demonstrated that SLPC can act as a potent liposomal platform to achieve cysteine/GSH-triggered controlled content release toward the goal of targeted drug delivery to diseased cells.
Mahbub Ullah, Kazi R. Shahriar, Mayesha B. Mustafa et al.· Bioconjugate chemistry· 0 citations
Delivering therapeutic macromolecules to defined cell populations in vivo remains a central unsolved problem in biomedicine. Proteins, nucleic acids and viral vectors are cleared by phagocytes, degraded by enzymes, blocked by endothelial and interstitial barriers, and trapped in acidifying endolysosomes. Pre-existing i...
It is demonstrated that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context-specific lipid design in ASO therapeutic development.
S. Roudi, H. Y. Estupiñán, O. Saher et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.